ECCMID 2022: In antibiotic development, scientific ingenuity meets a dysfunctional marketplace April 26, 2022 By Anette Breindl Antibiotics drugs discovery, Ursula Theuretzbacher told the audience at the 2022 European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), has more than one challenge to overcome.Read More
CDK4/6 inhibitor PRT-3645 prolongs survival in glioblastoma and brain-metastatic breast cancers April 26, 2022
CJRS-10671 and CJRS-10672, biotherapeutic candidates with promising antitumor efficacy in vivo April 25, 2022
CLN-978, a next-generation CD19-targeted therapeutic for the treatment of B-cell malignancies April 25, 2022
RSS
